Independent fund research. Built on SEC filings.

How we research funds

ETF · Leveraged & Inverse · ProShares

ProShares UltraShort Health Care (RXD)

Ticker RXD · · Holdings as of May 31, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
−11.9%annualized
1-yr return
−21.6%as of Dec 2025
Net assets
$5.3Mall share classes
Holdings
10

Bottom line

Is RXD a good fund? The bottom line

RXD is an actively managed leveraged & inverse ETF from ProShares.

Its expense ratio is 0.95% — about $95 a year on every $10,000 invested, cheaper than 82% of leveraged & inverse funds we track.

It returned −21.6% over one year, −11.9% a year over five years, −19.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $5.3 million in net assets and 10 holdings, its largest position is Repurchase Agreement (37.3%) and the top 10 make up 89.9% of the portfolio.

What stands out

  • Low cost: cheaper than 82% of leveraged & inverse peers

What to watch

  • Concentrated: top 10 holdings are 89.9% of assets
  • Small fund ($5.3 million) — small funds are likelier to close

Updated Nov 19, 2026

What RXD invests in

ProShares UltraShort Health Care (the Fund) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the S&P Health Care Select Sector Index (the Index).

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is designed to measure the performance of health care companies included in the S&P 500 Index. The S&P 500 Index is designed to measure the performance of 500 of the largest companies listed and domiciled in the U.S. The Index includes health care companies in the following industries according to the Global Industry Classification Standard (GICS): health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. These companies are then weighted based on market capitalization. The Indexs composition and the assigned weights are reevaluated every September with additional weight adjustments in March, June, and December. The Index is…

From the fund's prospectus (filed Sep 25, 2026).

RXD performance

Fund calendar-year total returns, 2016–2025 2016: −2.8%; 2017: −34.4%; 2018: −15.8%; 2019: −32.3%; 2020: −44.1%; 2021: −37.9%; 2022: +1.0%; 2023: +3.3%; 2024: +4.9%; 2025: −21.6% −3% 2016 −34% 2017 −16% 2018 −32% 2019 −44% 2020 −38% 2021 +1% 2022 +3% 2023 +5% 2024 −22% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
RXD−21.6%−11.9%−19.9%
Leveraged & Inverse median−7.7%−11.8%−13.5%

Source: Fund prospectus, as of Dec 31, 2025

Full RXD performance history →

What RXD costs

On a $10,000 investment, RXD's 0.95% expense ratio costs about $95 a year. The prospectus estimates $4,430 in total costs over 10 years (assuming 5% annual returns). The median leveraged & inverse fund charges 1.31%.

See the full RXD fee table →

RXD top 10 holdings

#Holding% of fund
1Repurchase Agreement37.33%
2Repurchase Agreement23.49%
3Repurchase Agreement17.62%
4Repurchase Agreement12.92%
5N/a1.14%
6N/a0.33%
7N/a-0.34%
8N/a-0.41%
9N/a-0.54%
10N/a-1.63%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 89.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to RXD

More funds like RXD →

RXD FAQ

What is the expense ratio of RXD?
RXD's expense ratio is 0.95%, which works out to about $95 a year for every $10,000 invested. The prospectus estimates total costs of $4,430 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RXD a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 82% of leveraged & inverse peers; concentrated: top 10 holdings are 89.9% of assets; small fund ($5.3 million) — small funds are likelier to close. This is general information, not personalized advice.
What does RXD hold?
RXD's largest holdings are Repurchase Agreement (37.3%), Repurchase Agreement (23.5%), Repurchase Agreement (17.6%), Repurchase Agreement (12.9%), N/a (1.1%). It holds 10 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is RXD's 5-year return?
RXD returned −11.9% a year over the five years ending Dec 31, 2025, and −19.9% a year over ten years. Past performance does not guarantee future results.
Who manages RXD?
RXD is offered by ProShares through Proshares Trust.